Neurology and Neurosurgery

31-45 of 64

• 

  RestartResume

  Optimizing VNS Parameters: Keys to Therapeutic Success

  MinuteCE®

  Optimizing VNS Parameters: Keys to Therapeutic Success

  • 

    

    Raman Sankar, MD, PhD

    Peer

  • 

    

    Scott Aaronson, MD

    Peer

  0.50 program credits

• 

  RestartResume

  Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond 

  CME/CE

  Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond 

  • 

    

    C. Michael Gibson, MD, MS

    Peer

  • 

    

    Roxana Mehran, MD, FSCAI

    Peer

  1.00 credits

• 

  RestartResume

  New Frontiers in the Treatment of DMD Across the Age Spectrum

  CME/CE

  New Frontiers in the Treatment of DMD Across the Age Spectrum

  • 

    

    Crystal Proud, MD

    Peer

  • 

    

    John Brandsema, MD

    Peer

  • 

    

    Omer Abdul Hamid, MD

    Peer

  1.00 credits

• 

  RestartResume

  Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics

  CME/CE

  Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Neelam Goyal, MD

    Peer

  0.75 credits

• 

  MinuteCE®

  Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  • 

    

    Hans Katzberg, MD

    Peer

  1.00 credits 10 episodes

• 

  RestartResume

  Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection

  CME/CE

  Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Jonathan Strober, MD

    Peer

  0.75 credits
• advertisement

• 

  RestartResume

  Living with gMG: Navigating Personal, Professional, and Mental Health Challenges

  MinuteCE®

  Living with gMG: Navigating Personal, Professional, and Mental Health Challenges

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Diagnostic Advances in gMG: Effective Tools and Techniques

  MinuteCE®

  Diagnostic Advances in gMG: Effective Tools and Techniques

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Hans Katzberg, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role

  MinuteCE®

  Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management

  MinuteCE®

  Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Hans Katzberg, MD

    Peer

  1.00 program credits

• 

  RestartResume

  A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained

  MinuteCE®

  A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

  New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy

  MinuteCE®

  New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits
• advertisement

• 

  RestartResume

  Managing Side Effects in FcRn Therapy: Best Practices for gMG

  MinuteCE®

  Managing Side Effects in FcRn Therapy: Best Practices for gMG

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Ocular to Generalized MG: How and Why the Disease Evolves

  MinuteCE®

  Ocular to Generalized MG: How and Why the Disease Evolves

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Hans Katzberg, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Preventing Myasthenic Crisis: Early Signs and Critical Interventions

  MinuteCE®

  Preventing Myasthenic Crisis: Early Signs and Critical Interventions

  • 

    

    Vera Bril, MD

    Peer

  • 

    

    Hans Katzberg, MD

    Peer

  1.00 program credits

• Prev
• 1
• 2
• 3
• 4
• 5
• Next